These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
8. Establishment of early donor engraftment after reduced-intensity allogeneic hematopoietic stem cell transplantation to potentiate the graft-versus-lymphoma effect against refractory lymphomas. Bishop MR; Hou JW; Wilson WH; Steinberg SM; Odom J; Castro K; Kasten-Sportes C; Gea-Banacloche J; Marchigiani D; Gress R; Fowler DH Biol Blood Marrow Transplant; 2003 Mar; 9(3):162-9. PubMed ID: 12652466 [TBL] [Abstract][Full Text] [Related]
9. [Induction of aGVHD after allogeneic hematopoietic stem cell transplantation for refractory or relapsed acute leukemia]. Sun J; Meng FY; Liu QF; Xu D; Xu B; Liu XL Ai Zheng; 2003 Dec; 22(12):1321-4. PubMed ID: 14693060 [TBL] [Abstract][Full Text] [Related]
10. Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation. Kako S; Izutsu K; Oshima K; Sato H; Kanda Y; Motokura T; Chiba S; Kurokawa M Am J Hematol; 2007 Oct; 82(10):937-9. PubMed ID: 17663389 [TBL] [Abstract][Full Text] [Related]
11. [Allogeneic hematopoietic stem-cell transplantation for hematological malignancies]. Michallet M; Dhedin N; Michallet AS Bull Cancer; 2001 Sep; 88(9):908-26. PubMed ID: 11604365 [TBL] [Abstract][Full Text] [Related]
12. A comparison between low intensity and reduced intensity conditioning in allogeneic hematopoietic stem cell transplantation for solid tumors. Conrad R; Remberger M; Cederlund K; Ringdén O; Barkholt L Haematologica; 2008 Feb; 93(2):265-72. PubMed ID: 18245651 [TBL] [Abstract][Full Text] [Related]
13. Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease. Lee S; Cho BS; Kim SY; Choi SM; Lee DG; Eom KS; Kim YJ; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Shin WS; Kim CC Biol Blood Marrow Transplant; 2007 Sep; 13(9):1083-94. PubMed ID: 17697971 [TBL] [Abstract][Full Text] [Related]
14. Allogeneic stem cell transplantation in a patient with relapsed Ewing sarcoma. Lucas KG; Schwartz C; Kaplan J Pediatr Blood Cancer; 2008 Jul; 51(1):142-4. PubMed ID: 18266223 [TBL] [Abstract][Full Text] [Related]
16. Immune reconstitution following myeloablative allogeneic hematopoietic stem cell transplantation: the impact of expanding CD28negative CD8+ T cells on relapse. Yakoub-Agha I; Saule P; Magro L; Cracco P; Duhamel A; Coiteux V; Bruno B; Dufossé F; Jouet JP; Dessaint JP; Labalette M Biol Blood Marrow Transplant; 2009 Apr; 15(4):496-504. PubMed ID: 19285638 [TBL] [Abstract][Full Text] [Related]
17. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia]. Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125 [TBL] [Abstract][Full Text] [Related]
18. Allogeneic blood stem cell transplantation in chronic myeloid leukaemia-chronic phase following conditioning with busulphan and cyclophosphamide: a follow up report. Saikia TK; Parikh PM; Tawde S; Amare-Kadam PS; Rajadhyaksha S; Chhaya S Natl Med J India; 2004; 17(2):71-3. PubMed ID: 15141598 [TBL] [Abstract][Full Text] [Related]
19. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005]. Faber E; Koza V; Vítek A; Mayer J; Sedlácek P; Zák P; Zapletalová J; Benesová K; Krejcová H; Steinerová K; Maresová I; Cetkovský P Vnitr Lek; 2006 Dec; 52(12):1172-80. PubMed ID: 17299910 [TBL] [Abstract][Full Text] [Related]
20. Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation. Remberger M Haematologica; 2005 Jul; 90(7):870. PubMed ID: 15996922 [No Abstract] [Full Text] [Related] [Next] [New Search]